These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14224432)

  • 21. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HAGEMAN FACTOR AND IN VIVO ACTIVATION OF FIBRINOLYSIS.
    HOLEMANS R; ROBERTS HR
    J Lab Clin Med; 1964 Nov; 64():778-86. PubMed ID: 14226397
    [No Abstract]   [Full Text] [Related]  

  • 24. QUANTITATIVE EVALUATION OF FIBRINOLYTIC ENZYMES IN A SIMULATED HUMAN SYSTEM.
    MUNSON AE; BACK N; AMBRUS CM; LASSMAN H; LIPPSCHUTZ E; AMBRUS JL
    J Appl Physiol; 1964 May; 19():536-9. PubMed ID: 14174592
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP; Ferguson JH
    Thromb Diath Haemorrh; 1970 Oct; 24(1):1-9. PubMed ID: 4249468
    [No Abstract]   [Full Text] [Related]  

  • 26. Hageman complement and factor.
    Kim Z
    Ann Allergy; 1977 Mar; 38(3):211-4. PubMed ID: 842908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [FIBRINOLYSIS. (PHYSIOLOGY; PATHOLOGY; FIBRINOLYTIC THERAPY)].
    LOMBARDI V; MATTII R
    G Gerontol Suppl; 1962; 31():SUPPL30:1-165. PubMed ID: 14043858
    [No Abstract]   [Full Text] [Related]  

  • 28. [Kinetics of the fibrinolytic activity of the Hageman factor].
    Aznar J; Macarulla JM
    Rev Esp Fisiol; 1965 Jun; 21(2):59-64. PubMed ID: 5891741
    [No Abstract]   [Full Text] [Related]  

  • 29. Thromboplastic and fibrinolytic activities in tissues of the eye.
    PANDOLFI M; COCCHERI S; ASTRUP T
    Proc Soc Exp Biol Med; 1962 Jan; 109():159-61. PubMed ID: 14483505
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of HF (factor XII) in the pathogenesis of the thrombolytic state induced by venous occlusion.
    Iatridis SG; Iatridis PG; Ferguson JH
    Thromb Diath Haemorrh; 1966 Jul; 16(1):207-17. PubMed ID: 4229626
    [No Abstract]   [Full Text] [Related]  

  • 31. [FIBRINOLYTIC ACTIVITY. ITS IMPORTANCE IN ATHEROSCLEROSIS].
    BROCHIER M
    Sem Hop; 1965 Jan; 41():230-1. PubMed ID: 14295388
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood coagulation and fibrinolysis.
    Heimburger N; Trobisch H
    Angew Chem Int Ed Engl; 1971 Feb; 10(2):85-97. PubMed ID: 4995468
    [No Abstract]   [Full Text] [Related]  

  • 33. [Changes in blood coagulation factors and fibrinolytic activity in leukemias].
    EFENDIEV FA; ABDULLAEV MM; BAKHSHIEVA EB
    Probl Gematol Pereliv Krovi; 1961 Oct; 6():19-28. PubMed ID: 13889347
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
    Iatridis PG; Gadarowski JJ; Iatridis SG
    Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [OBSERVATIONS ON THE ACTIVE PRINCIPLES OF THE HAGEMAN FACTOR (FACTOR XII)].
    HAANEN C; SCHOENMAKERS JG
    Ned Tijdschr Geneeskd; 1965 Jun; 109():1174-5. PubMed ID: 14320599
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conditions of the coagulation system and fibrinolytic activity of the blood in patients with splenomegaly of varied etiology].
    EFENDIEV FA; AKHUNDOVA AM; ABDULLAEV MM
    Khirurgiia (Mosk); 1962 Feb; 38():3-8. PubMed ID: 13889348
    [No Abstract]   [Full Text] [Related]  

  • 38. Hageman factor-independent fibrinolytic pathway.
    Schreiber AD; Austen KF
    Clin Exp Immunol; 1974 Aug; 17(4):587-600. PubMed ID: 4143120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Relationship among coagulation, fibrinolysis, kinin formation and factor XII].
    Saito H
    Rinsho Ketsueki; 1978 Jun; 19(6):785-91. PubMed ID: 713043
    [No Abstract]   [Full Text] [Related]  

  • 40. WETTABILITY OF VASCULAR ENDOTHELIUM.
    ZUBAIROV DM; REPEIKOV AV; TIMERBAEV VN
    Fed Proc Transl Suppl; 1964; 23():317-21. PubMed ID: 14145664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.